Nucleic acid‐mediated inflammatory diseases

Enzymes that degrade nucleic acids are emerging as important players in the pathogenesis of inflammatory disease. This is exemplified by the recent identification of four genes that cause the childhood inflammatory disorder, Aicardi‐Goutières syndrome (AGS). This is an autosomal recessive neurological condition whose clinical and immunological features parallel those of congenital viral infection. The four AGS genes encode two nucleases: TREX1 and the hetero‐trimeric Ribonuclease H2 (RNase H2) complex. The biochemical activity of these enzymes was initially characterised 30 years ago but a role in neurological inflammation was entirely unanticipated until they were found to be mutated in AGS. This has led to a hypothesis that accumulation of intracellular nucleic acids occurs as a consequence of mutation in these enzymes and triggers an inflammatory response through activation of innate immune pattern recognition receptors. ©2007 Wiley Periodicals, Inc BioEssays 30:833–842, 2008. © 2008 Wiley Periodicals, Inc.

[1]  Y. Crow,et al.  Aicardi‐Goutières syndrome: an important Mendelian mimic of congenital infection , 2008, Developmental medicine and child neurology.

[2]  E. Aronica,et al.  Astrocytes produce interferon‐alpha and CXCL10, but not IL‐6 or CXCL8, in aicardi‐Goutières syndrome , 2008, Glia.

[3]  E. Latz,et al.  The DNA sugar backbone 2' deoxyribose determines toll-like receptor 9 activation. , 2008, Immunity.

[4]  J. Tschopp,et al.  The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response , 2008, Nature.

[5]  D. Barnes,et al.  Trex1 Exonuclease Degrades ssDNA to Prevent Chronic Checkpoint Activation and Autoimmune Disease , 2007, Cell.

[6]  M. Lieber,et al.  Mechanism of R-Loop Formation at Immunoglobulin Class Switch Sequences , 2007, Molecular and Cellular Biology.

[7]  A. Green,et al.  Clinical and molecular phenotype of Aicardi-Goutieres syndrome. , 2007, American journal of human genetics.

[8]  G. Vereb,et al.  Ribonucleoprotein-masked nicks at 50-kbp intervals in the eukaryotic genomic DNA , 2007, Proceedings of the National Academy of Sciences.

[9]  S. Nelson,et al.  C-terminal truncations in human 3′-5′ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy , 2007, Nature Genetics.

[10]  J. Lieberman,et al.  Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus , 2007, Nature Genetics.

[11]  K. Honda,et al.  DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response , 2007, Nature.

[12]  D. Barnes,et al.  Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome. , 2007, American journal of human genetics.

[13]  G. Gallagher,et al.  Interferon lambda-1 (IFN-λ1/IL-29) induces ELR− CXC chemokine mRNA in human peripheral blood mononuclear cells, in an IFN-γ-independent manner , 2007, Genes and Immunity.

[14]  J. Derisi,et al.  An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors , 2007, Proceedings of the National Academy of Sciences.

[15]  Hung Fan,et al.  A new human retrovirus associated with prostate cancer , 2007, Proceedings of the National Academy of Sciences.

[16]  S. Akira,et al.  Nucleic acid agonists for Toll‐like receptor 7 are defined by the presence of uridine ribonucleotides , 2006, European journal of immunology.

[17]  V. Pascual,et al.  Systemic lupus erythematosus: all roads lead to type I interferons. , 2006, Current opinion in immunology.

[18]  Gunther Hartmann,et al.  5'-Triphosphate RNA Is the Ligand for RIG-I , 2006, Science.

[19]  H. Yoshikawa,et al.  Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages , 2006, Nature.

[20]  Annalisa Ballarini,et al.  Familial chilblain lupus, a monogenic form of cutaneous lupus erythematosus, maps to chromosome 3p. , 2006, American journal of human genetics.

[21]  C. Ponting,et al.  Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection , 2006, Nature Genetics.

[22]  D. Barnes,et al.  Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus , 2006, Nature Genetics.

[23]  J. Lieberman,et al.  The exonuclease TREX1 is in the SET complex and acts in concert with NM23-H1 to degrade DNA during granzyme A-mediated cell death. , 2006, Molecular cell.

[24]  J. Gómez-Reino,et al.  Association of a non-synonymous single-nucleotide polymorphism of DNASEI with SLE susceptibility. , 2006, Rheumatology.

[25]  D. J. Driscoll,et al.  Lupus-like disease and high interferon levels corresponding to trisomy of the type I interferon cluster on chromosome 9p. , 2006, Arthritis and rheumatism.

[26]  Shizuo Akira,et al.  Innate immune recognition of viral infection , 2006, Nature Immunology.

[27]  J. Dalgaard,et al.  The wild‐type Schizosaccharomyces pombe mat1 imprint consists of two ribonucleotides , 2006, EMBO reports.

[28]  Ram R. Singh SLE: translating lessons from model systems to human disease. , 2005, Trends in immunology.

[29]  S. Akira,et al.  Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus , 2005, The Journal of experimental medicine.

[30]  Miki Ii,et al.  Roles of SGS1, MUS81, and RAD51 in the repair of lagging-strand replication defects in Saccharomyces cerevisiae , 2005, Current Genetics.

[31]  D. Golenbock,et al.  Human cardiac inflammatory responses triggered by Coxsackie B viruses are mainly Toll‐like receptor (TLR) 8‐dependent , 2005, Cellular microbiology.

[32]  L. Lagae,et al.  A second locus for Aicardi-Goutières syndrome at chromosome 13q14–21 , 2005, Journal of Medical Genetics.

[33]  Y. Crow,et al.  Genetic syndromes mimic congenital infections. , 2005, The Journal of pediatrics.

[34]  H. Lyall,et al.  Clinical presentation of congenital viral infections , 2005 .

[35]  S. Miller,et al.  Differential activation of astrocytes by innate and adaptive immune stimuli , 2005, Glia.

[36]  S. Goodbourn,et al.  The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[37]  G. Trinchieri,et al.  Plasmacytoid dendritic cells in immunity , 2004, Nature Immunology.

[38]  H. Shin,et al.  Common DNase I polymorphism associated with autoantibody production among systemic lupus erythematosus patients. , 2004, Human molecular genetics.

[39]  K. Yasutomo,et al.  DNaseI in pathogenesis of systemic lupus erythematosus. , 2004, Clinical immunology.

[40]  D. Barnes,et al.  Gene-Targeted Mice Lacking the Trex1 (DNase III) 3′→5′ DNA Exonuclease Develop Inflammatory Myocarditis , 2004, Molecular and Cellular Biology.

[41]  Shizuo Akira,et al.  The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses , 2004, Nature Immunology.

[42]  Akiko Iwasaki,et al.  Recognition of single-stranded RNA viruses by Toll-like receptor 7. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Shizuo Akira,et al.  Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA , 2004, Science.

[44]  S. Akira,et al.  Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 , 2004, Science.

[45]  C. Jacobs,et al.  Decreased phagocytosis of apoptotic cells in diseased SLE mice. , 2004, Journal of autoimmunity.

[46]  P. Heyder,et al.  Cooperation between C1q and DNase I in the clearance of necrotic cell-derived chromatin. , 2004, Arthritis and rheumatism.

[47]  C. J. Evans,et al.  DNase II: genes, enzymes and function. , 2003, Gene.

[48]  Thierry Heidmann,et al.  Survey of Human Genes of Retroviral Origin: Identification and Transcriptome of the Genes with Coding Capacity for Complete Envelope Proteins , 2003, Journal of Virology.

[49]  U. Hübscher,et al.  DNA polymerase beta can incorporate ribonucleotides during DNA synthesis of undamaged and CPD-damaged DNA. , 2003, Journal of molecular biology.

[50]  M. Lieber,et al.  R-loops at immunoglobulin class switch regions in the chromosomes of stimulated B cells , 2003, Nature Immunology.

[51]  T. Fujikawa,et al.  Intracranial Calcification With Congenital Rubella Syndrome in a Mother With Serologic Immunity , 2003, Journal of child neurology.

[52]  P. Walsh,et al.  RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. , 2003, The Journal of urology.

[53]  R. Crouch,et al.  Failure to produce mitochondrial DNA results in embryonic lethality in Rnaseh1 null mice. , 2003, Molecular cell.

[54]  F. Martinon,et al.  Overexpression of Helicard, a CARD-Containing Helicase Cleaved during Apoptosis, Accelerates DNA Degradation , 2002, Current Biology.

[55]  M. Shlomchik,et al.  Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors , 2002, Nature.

[56]  K. Klinger,et al.  Germline mutations in the ribonuclease L gene in families showing linkage with HPC1 , 2002, Nature Genetics.

[57]  T. Taniguchi,et al.  The interferon-α/β system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors , 2002 .

[58]  Paul B. Fisher,et al.  mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[59]  R. Flavell,et al.  Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.

[60]  T. Horiuchi,et al.  Mutation of DNASE1 in people with systemic lupus erythematosus , 2001, Nature Genetics.

[61]  Dan J. Mazur,et al.  Structure and Expression of the TREX1 and TREX2 3′→5′ Exonuclease Genes* , 2001, The Journal of Biological Chemistry.

[62]  G. Hughes,et al.  Systemic lupus erythematosus , 2001, The Lancet.

[63]  S. Akira,et al.  A Toll-like receptor recognizes bacterial DNA , 2000, Nature.

[64]  M. Itaya,et al.  The absence of ribonuclease H1 or H2 alters the sensitivity of Saccharomyces cerevisiae to hydroxyurea, caffeine and ethyl methanesulphonate: implications for roles of RNases H in DNA replication and repair , 2000, Genes to cells : devoted to molecular & cellular mechanisms.

[65]  D. Isenberg,et al.  Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. , 2000, Arthritis and rheumatism.

[66]  C. Woods,et al.  Aicardi-Goutières syndrome displays genetic heterogeneity with one locus (AGS1) on chromosome 3p21. , 2000, American journal of human genetics.

[67]  T. Möröy,et al.  Features of systemic lupus erythematosus in Dnase1-deficient mice , 2000, Nature Genetics.

[68]  J. Sgouros,et al.  A human DNA editing enzyme homologous to the Escherichia coli DnaQ/MutD protein , 1999, The EMBO journal.

[69]  S. Henriksen,et al.  Structural and functional neuropathology in transgenic mice with CNS expression of IFN-α 1 Published on the World Wide Web on 17 March 1999. 1 , 1999, Brain Research.

[70]  N. Kadowaki,et al.  The nature of the principal type 1 interferon-producing cells in human blood. , 1999, Science.

[71]  D. Rebouillat,et al.  The human 2',5'-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[72]  M. Itaya,et al.  Identification of the genes encoding Mn2+-dependent RNase HII and Mg2+-dependent RNase HIII from Bacillus subtilis: classification of RNases H into three families. , 1999, Biochemistry.

[73]  F. Bloom,et al.  Transgenic expression of IFN-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration. , 1998, Journal of immunology.

[74]  P. Frank,et al.  Cloning of the cDNA encoding the large subunit of human RNase HI, a homologue of the prokaryotic RNase HII. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[75]  L. Rönnblom,et al.  Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha- producing cells. , 1998, Journal of autoimmunity.

[76]  R. Voll,et al.  Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. , 1998, Arthritis and rheumatism.

[77]  R. Martí,et al.  Acrocyanosis Induced by Interferon α2a , 1998, Dermatology.

[78]  P. Lachmann,et al.  Measurement of deoxyribonuclease I (DNase) in the serum and urine of systemic lupus erythematosus (SLE)‐prone NZB/NZW mice by a new radial enzyme diffusion assay , 1997, Clinical and experimental immunology.

[79]  R. Bambara,et al.  Enzymes and Reactions at the Eukaryotic DNA Replication Fork* , 1997, The Journal of Biological Chemistry.

[80]  D. Farge,et al.  Raynaud's phenomenon and digital necrosis induced by interferon‐alpha , 1996, The British journal of dermatology.

[81]  A. Raymond,et al.  Brain calcification in patients with cerebral lupus , 1996, Lupus.

[82]  R. Aguilera,et al.  Characterization of an endonuclease activity which preferentially cleaves the G-rich immunoglobulin switch repeat sequences. , 1996, Molecular immunology.

[83]  L. Liu,et al.  Overexpression of RNase H partially complements the growth defect of an Escherichia coli delta topA mutant: R-loop formation is a major problem in the absence of DNA topoisomerase I. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[84]  Robert H. Silverman,et al.  Expression cloning of 2-5A-dependent RNAase: A uniquely regulated mediator of interferon action , 1993, Cell.

[85]  J. Walder,et al.  Ribonuclease H from K562 human erythroleukemia cells. Purification, characterization, and substrate specificity. , 1991, The Journal of biological chemistry.

[86]  K. Moelling,et al.  Interaction of HIV-1 ribonuclease H with polypurine tract containing RNA-DNA hybrids. , 1990, Biochemistry.

[87]  J. Farber,et al.  Identification of CRG-2. An interferon-inducible mRNA predicted to encode a murine monokine. , 1990, The Journal of biological chemistry.

[88]  I. Kerr,et al.  Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon , 1990, Cell.

[89]  R. Hogrefe,et al.  Kinetic analysis of Escherichia coli RNase H using DNA-RNA-DNA/DNA substrates. , 1990, The Journal of biological chemistry.

[90]  J. Ravetch,et al.  Biochemical characterization of a gamma interferon-inducible cytokine (IP-10) , 1987, The Journal of experimental medicine.

[91]  D. Dickson,et al.  AIDS: Calcification of the basal ganglia in infants and children , 1986, Neurology.

[92]  G. Ponsot,et al.  Intrathecal synthesis of different alpha‐interferons in patients with various neurological diseases , 1985, Acta neurologica Scandinavica.

[93]  J. Aicardi,et al.  A Progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis , 1984, Annals of neurology.

[94]  P. Lebon,et al.  Synthesis of intrathecal interferon in systemic lupus erythematosus with neurological complications. , 1983, British medical journal.

[95]  G. Edelman,et al.  Properties of Deoxyribonuclease III from Mammalian Tissues , 1969 .

[96]  G. Gallagher,et al.  Interferon lambda-1 (IFN-lambda1/IL-29) induces ELR(-) CXC chemokine mRNA in human peripheral blood mononuclear cells, in an IFN-gamma-independent manner. , 2007, Genes and immunity.

[97]  M. Lieber,et al.  Detection and structural analysis of R-loops. , 2006, Methods in enzymology.

[98]  L. Pasquier,et al.  Orphanet Journal of Rare Diseases BioMed Central Review , 2006 .

[99]  P. Backlund,et al.  RNase H2 of Saccharomyces cerevisiae is a complex of three proteins. , 2004, Nucleic acids research.

[100]  E. Tan,et al.  Serum deoxyribonuclease I and clinical activity in systemic lupus erythematosus , 2004, Rheumatology International.

[101]  T. Taniguchi,et al.  The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. , 2002, Current opinion in immunology.

[102]  I. Baumann,et al.  Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. , 2002, Arthritis and rheumatism.

[103]  S. Henriksen,et al.  Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. , 1999, Brain research.

[104]  R. Martí,et al.  Acrocyanosis induced by interferon alpha(2a). , 1998, Dermatology.

[105]  J. Bale,et al.  Neuroradiographic abnormalities in congenital cytomegalovirus infection. , 1985, Pediatric neurology.

[106]  G. Edelman,et al.  Properties of deoxyribonuclease 3 from mammalian tissues. , 1969, The Journal of biological chemistry.